BRIEF-Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement-June 2024-www.financetom.com

BRIEF-Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement

Jun 21, 2024 2:06 PM

June 21 (Reuters) - Eiger Biopharmaceuticals Inc ( EIGRQ ):

* COMPANY AND AMYLYX ENTERED INTO AN ASSET PURCHASE

AGREEMENT

* AMYLYX AGREED TO BUY ALL OF CO'S RIGHTS, TITLE,INTERESTS

ASSETS,INTERESTS USED IN DEVELOPMENT,

MANUFACTURE,COMMERCIALIZATION OF AVEXITIDE

* ASSET PURCHASE AGREEMENT FOR $35.1 MILLION, PLUS AGGREGATE

AMOUNT OF DETERMINED CURE COSTS AND ASSUMED LIABILITIES

Previous page： Synopsys revenue forecast beats estimates on AI chip boom, shares up Next page： Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Synopsys revenue forecast beats estimates on AI chip boom, shares up

Feb 26, 2025

Feb 26 (Reuters) - Synopsys ( SNPS ) on Wednesday forecast second-quarter revenue above Wall Street estimates, citing growing demand for its software used in designing chips. The company's shares rose 2.45% to $482 in after-hours trading after the results were released. Companies such as Amazon ( AMZN ), Google and Apple ( AAPL ) are investing in designing their...

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports

Feb 26, 2025

Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million contract for bird flu shots that was awarded to Moderna ( MRNA ), Bloomberg News reported on Wednesday, citing people familiar with the matter. The U.S. government had awarded Moderna ( MRNA ) $590 million in January to advance the development of its bird flu vaccine. ...

Marriott Vacations Q4 Profit Lower, Revenue Up; Issues Guidance

Feb 26, 2025

05:47 PM EST, 02/26/2025 (MT Newswires) -- Marriott Vacations Worldwide ( VAC ) reported Q4 adjusted earnings late Wednesday of $1.86 per diluted share, down from $1.88 a year earlier. Analysts polled by FactSet expected $1.52. Revenue for the quarter ended Dec. 31 was $1.33 billion, down from $1.19 billion a year earlier. Analysts surveyed by FactSet expected $1.24 billion....

Rush Street Interactive Q4 Adjusted Earnings, Revenue Rise; 2025 Revenue Guidance Set

Feb 26, 2025

05:47 PM EST, 02/26/2025 (MT Newswires) -- Rush Street Interactive ( RSI ) reported Q4 adjusted earnings late Wednesday of $0.07 a share, up from $0.01 a year earlier. Analysts polled by FactSet expected $0.06. Revenue in the three months ended Dec. 31 rose to $254.2 million from $193.9 million a year earlier. Analysts polled by FactSet expected $245.5 million....